Patrick YW, Santosh K. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507.
Article
Google Scholar
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842–50.
Article
CAS
PubMed
Google Scholar
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-Oncology. 2015;17(suppl 4):v1–62.
Article
Google Scholar
Badeaux AI, Yang Y, Cardenas K, Vemulapalli V, Chen K, Kusewitt D, Richie E, Li W, Bedford MT. Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J Biol Chem. 2011;287(1):429–37.
Article
PubMed
PubMed Central
Google Scholar
Li Y, Park J, Piao L, Kong G, Kim Y, Park KA, Zhang T, Hong J, Hur GM, Seok JH, et al. PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage. Cell Signal. 2013;25(1):74–84.
Article
CAS
PubMed
Google Scholar
Zhang T, Park KA, Li Y, Byun HS, Jeon J, Lee Y, Hong JH, Kim JM, Huang SM, Choi SW, et al. PHF20 regulates NF-kappaB signalling by disrupting recruitment of PP2A to p65. Nat Commun. 2013;4:2062.
PubMed
PubMed Central
Google Scholar
Pallasch CP, Struss A, Munnia A, König J, Steudel W, Fischer U, Meese E. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival. Int J Cancer. 2005;117(3):456–9.
Article
CAS
PubMed
Google Scholar
Fischer U, Struss AK, Hemmer D, Pallasch CP, Steudel WI, Meese E. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls. Clin Exp Immunol. 2001;126(2):206–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol. 2002;169(2):1102–9.
Article
CAS
PubMed
Google Scholar
Behrends U, Schneider I, Rossler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Muller-Weihrich S, Graubner U, et al. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int J Cancer. 2003;106(2):244–51.
Article
CAS
PubMed
Google Scholar
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol. 2007;25(6):663–8.
Article
CAS
PubMed
Google Scholar
Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007;17(10):1537–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. Whole pathway scope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinform. 2006;7:30.
Article
Google Scholar
Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42(D1):D199–205.
Article
CAS
PubMed
Google Scholar
Wei Z, Li H. A Markov random field model for network-based analysis of genomic data. Bioinformatics. 2007;23(12):1537–44.
Article
CAS
PubMed
Google Scholar
Tang N, Ma L, Lin XY, Zhang Y, Yang DL, Wang EH, Qiu XS. Expression of PHF20 protein contributes to good prognosis of NSCLC and is associated with Bax expression. Int J Clin Exp Pathol. 2015;8(10):12198–206.
PubMed
PubMed Central
Google Scholar
Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, Yasui W, Inai K, Kohno N, Nakamura Y. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol. 2006;29(3):567–75.
CAS
PubMed
Google Scholar
Nikolova T, Christmann M, Kaina B. FEN1 is overexpressed in testis, lung and brain tumors. Anticancer Res. 2009;29(7):2453–9.
CAS
PubMed
Google Scholar
Ying N, Wang S, Xu H, Wang Y. Association between FEN1 polymorphisms -69G> A and 4150G> T with susceptibility in human disease: a meta-analysis. Iran J Public Health. 2015;44(12):1574–9.
PubMed
PubMed Central
Google Scholar
Chen Y, Zhang X, Qiu X, Li J, Yuan Q, Jiang T, Yang M. Functional FEN1 genetic variants and haplotypes are associated with glioma risk. J Neuro-Oncol. 2013;111(2):145–51.
Article
CAS
Google Scholar
Xu BJ, An QA, Srinivasa GS, Yan W, Pierce LA, Abel TW, Rush SZ, Cooper MK, Ye F, Shyr Y, et al. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma. Int J Oncol. 2012;40(6):1995–2003.
CAS
PubMed
Google Scholar
Pećina-Šlaus N, Gotovac K, Kafka A, Tomas D, Borovečki F. Genetic changes observed in a case of adult pilocytic astrocytoma revealed by array CGH analysis. Mol Cytogenet. 2014;7:95.
Article
PubMed
PubMed Central
Google Scholar
Cui G, Park S, Badeaux AI, Kim D, Lee J, Thompson JR, Yan F, Kaneko S, Yuan Z, Botuyan MV, et al. PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53. Nat Struct Mol Biol. 2012;19(9):916–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S, Tanic N. Identification of genes associated with non-small-cell lung cancer promotion and progression. Lung Cancer. 2010;67(2):151–9.
Article
PubMed
Google Scholar
Lasho TL, Pardanani A, Tefferi A, Smith DI. Altered expression of tumor suppressor PHF20 in myeloproliferative neoplasms. Leukemia. 2014;28(8):1762–4.
Article
CAS
PubMed
Google Scholar
Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell Mol Life Sci. 2008;65(19):2964–78.
Article
CAS
PubMed
Google Scholar
Spyridakis S, Leondaritis G, Nakos G, Lekka ME, Galanopoulou D. A specific phospholipase C activity regulates phosphatidylinositol levels in lung surfactant of patients with acute respiratory distress syndrome. Am J Resp Cell Mol. 2010;42(3):357–62.
Article
CAS
Google Scholar
Kong G, Chang YI, You X, Ranheim EA, Zhou Y, Burd CE, Zhang J. The ability of endogenous Nras oncogenes to initiate leukemia is codon-dependent. Leukemia. 2016;30(9):1935–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jakob JA, Bassett RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, et al. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer Am Cancer Soc. 2012;118(16):4014–23.
CAS
Google Scholar
Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJ. Mutational profiling of kinases in glioblastoma. BMC Cancer. 2014;14:718.
Article
PubMed
PubMed Central
Google Scholar
Tsurushima H, Tsuboi K, Yoshii Y, Ohno T, Meguro K, Nose T. Expression of N-ras gene in gliomas. Neurol Med Chir (Tokyo). 1996;36(10):704–8.
Article
CAS
PubMed
Google Scholar
Herrero-Gonzalez S, Di Cristofano A. New routes to old places: PIK3R1 and PIK3R2 Join PIK3CA and PTEN as endometrial cancer genes. Cancer Discov. 2011;1(2):106–7.
Article
CAS
PubMed
Google Scholar
Kita D, Yonekawa Y, Weller M, Ohgaki H. PIK3CA alterations in primary (de novo) and secondary glioblastomas. Acta Neuropathol. 2007;113(3):295–302.
Article
CAS
PubMed
Google Scholar
Li L, Yang XJ. Molecular and functional characterization of histone deacetylase 4 (HDAC4). Methods Mol Biol. 2016;1436:31–45.
Article
PubMed
Google Scholar
Oehme I, Deubzer HE, Wegener D, Pickert D, Linke JP, Hero B, Kopp-Schneider A, Westermann F, Ulrich SM, von Deimling A, et al. Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin Cancer Res. 2009;15(1):91–9.
Article
CAS
PubMed
Google Scholar
Zeng LS, Yang XZ, Wen YF, Mail SJ, Wang MH, Zhang MY, Zheng XF, Wang HY. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. Aging (Albany NY). 2016;8(6):1236–49.
Article
PubMed
PubMed Central
Google Scholar
Pei Y, Liu K, Wang J, Garancher A, Tao R, Esparza LA, Maier DL, Udaka YT, Murad N, Morrissy S, et al. HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma. Cancer Cell. 2016;29(3):311–23.
Article
CAS
PubMed
PubMed Central
Google Scholar